Matthew Burgess

Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial

Peter Schmid, Jacinta Abraham, Stephen Chan et al. · Journal of Clinical Oncology · 2019 · 373 citations · Full text

Runx1-mediated hematopoietic stem-cell emergence is controlled by a Gata/Ets/SCL-regulated enhancer

Wade Nottingham, Andrew Jarratt, Matthew Burgess et al. · Blood · 2007 · 248 citations · Full text

Cx3CR1 Expression Identifies Distinct Macrophage Populations That Contribute Differentially to Inflammation and Repair

Matthew Burgess, Kate Wicks, Marina Gardasevic et al. · ImmunoHorizons · 2019 · 109 citations · Full text

Randomised controlled trial of intravenous nafamostat mesylate in COVID pneumonitis: Phase 1b/2a experimental study to investigate safety, Pharmacokinetics and Pharmacodynamics

Tom Quinn, Erin Gaughan, Annya Bruce et al. · EBioMedicine · 2022 · 51 citations · Full text

Direct Activation of NADPH Oxidase 2 by 2-Deoxyribose-1-Phosphate Triggers Nuclear Factor Kappa B-Dependent Angiogenesis

Dina Vara, Joanna M. Watt, Tiago M. Fortunato et al. · Antioxidants and Redox Signaling · 2017 · 37 citations · Full text